$83.97
-0.04 (-0.05%)
DaVita, Inc. (NYSE:DVA)
CAPS Rating:
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.